Addition of Regular Insulin to Ternary Parenteral Nutrition: A Stability Study.

immunoassay parenteral nutrition solutions regular insulin stability

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
27 Mar 2021
Historique:
received: 01 03 2021
revised: 20 03 2021
accepted: 24 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

Parenteral nutrition (PN) is a complex medium in which added insulin can become unstable. The aim of this study is, therefore, to evaluate the stability of insulin in PN and to identify influencing factors. A total of 20 IU/L of regular insulin was added to PN in either glass or Ethylene Vinyl Acetate (EVA) containers. A 24 h stability study was performed via an electrochemiluminescence immunoassay in different media: A ternary PN admixture, separate compartments of the PN bag and a binary admixture. This study was repeated in the absence of zinc, with the addition of serum albumin or tween and with pH adjustment (3.6 or 6.3). Insulin concentration at t time was expressed as a percentage of the initial insulin concentration. Analysis of covariance (ANCOVA) was applied to determine the factors that influence insulin stability. In all PN admixtures, the insulin concentration ratio decreased, stabilising at a 60% and then plateauing after 6 h. At pH 3.6, the ratio was above 90%, while at pH 6.3 it decreased, except in the amino acid solution. ANCOVA (r A low pH level seems to stabilise insulin in PN admixtures. The influence of dextrose content suggests that insulin glycation may influence stability.

Sections du résumé

BACKGROUND BACKGROUND
Parenteral nutrition (PN) is a complex medium in which added insulin can become unstable. The aim of this study is, therefore, to evaluate the stability of insulin in PN and to identify influencing factors.
METHODS METHODS
A total of 20 IU/L of regular insulin was added to PN in either glass or Ethylene Vinyl Acetate (EVA) containers. A 24 h stability study was performed via an electrochemiluminescence immunoassay in different media: A ternary PN admixture, separate compartments of the PN bag and a binary admixture. This study was repeated in the absence of zinc, with the addition of serum albumin or tween and with pH adjustment (3.6 or 6.3). Insulin concentration at t time was expressed as a percentage of the initial insulin concentration. Analysis of covariance (ANCOVA) was applied to determine the factors that influence insulin stability.
RESULTS RESULTS
In all PN admixtures, the insulin concentration ratio decreased, stabilising at a 60% and then plateauing after 6 h. At pH 3.6, the ratio was above 90%, while at pH 6.3 it decreased, except in the amino acid solution. ANCOVA (r
CONCLUSION CONCLUSIONS
A low pH level seems to stabilise insulin in PN admixtures. The influence of dextrose content suggests that insulin glycation may influence stability.

Identifiants

pubmed: 33801784
pii: pharmaceutics13040458
doi: 10.3390/pharmaceutics13040458
pmc: PMC8066181
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Diabetes Care. 1991 Jan;14(1):61-3
pubmed: 1991437
Clin Nutr. 2012 Aug;31(4):526-34
pubmed: 22230256
Gastroenterol Res Pract. 2011;2011:
pubmed: 20811546
Diabet Med. 1986 Nov-Dec;3(6):532-6
pubmed: 2951208
JPEN J Parenter Enteral Nutr. 2018 Jul;42(5):846-854
pubmed: 28792863
Anesthesiology. 1974 Apr;40(4):400-4
pubmed: 4856440
Nutr Clin Pract. 2009 Oct-Nov;24(5):626-34
pubmed: 19564627
Acta Pharm Nord. 1992;4(3):149-58
pubmed: 1418641
J Pharm Sci. 1983 Dec;72(12):1472-3
pubmed: 6363674
JPEN J Parenter Enteral Nutr. 1999 Mar-Apr;23(2):67-74
pubmed: 10081995
Anal Bioanal Chem. 2017 May;409(14):3677-3684
pubmed: 28357482
Acta Paediatr. 2011 Sep;100(9):1200-5
pubmed: 21418099
Nutr Clin Pract. 2004 Apr;19(2):120-8
pubmed: 16215099
Am J Hosp Pharm. 1981 Jul;38(7):995-7
pubmed: 7020415
Biochim Biophys Acta. 1975 Sep 8;404(1):164-8
pubmed: 1174556
JPEN J Parenter Enteral Nutr. 1987 Jan-Feb;11(1):97-9
pubmed: 3102788
Curr Diab Rep. 2013 Feb;13(1):155-62
pubmed: 23065369
Dan Med J. 2018 Apr;65(4):
pubmed: 29619926
Diabetes Res Clin Pract. 2008 Jun;80(3):e11-3
pubmed: 18395926
J Chromatogr A. 1995 May 5;699(1-2):383-8
pubmed: 7757211
Diabetes Care. 1987 May-Jun;10(3):348-51
pubmed: 3297580
FEBS Lett. 1979 Apr 1;100(1):133-6
pubmed: 437095
J Paediatr Child Health. 2000 Jun;36(3):216-20
pubmed: 10849219
Clin Nutr ESPEN. 2019 Apr;30:204-207
pubmed: 30904223
JPEN J Parenter Enteral Nutr. 2014 Mar-Apr;38(3):296-333
pubmed: 24280129
Anal Biochem. 2011 Jul 1;414(1):38-46
pubmed: 21315060
Diabetes Care. 2010 Apr;33(4):739-41
pubmed: 20040658
J Food Drug Anal. 2016 Jan;24(1):214-219
pubmed: 28911406
Clin Nutr. 2020 Feb;39(2):388-394
pubmed: 30930133
Pharmacotherapy. 2015 Feb;35(2):148-57
pubmed: 25689245
JPEN J Parenter Enteral Nutr. 2017 Sep;41(7):1110-1118
pubmed: 27091835
Clin Nutr. 2020 Jun;39(6):1645-1666
pubmed: 32359933
Colloids Surf B Biointerfaces. 2012 Dec 1;100:69-76
pubmed: 22766284
JPEN J Parenter Enteral Nutr. 2011 Jul;35(4):505-10
pubmed: 21632954
JPEN J Parenter Enteral Nutr. 2004 Nov-Dec;28(6):439-41
pubmed: 15568292
J Acad Nutr Diet. 2013 Feb;113(2):263-8
pubmed: 23351630
Am J Hosp Pharm. 1977 Apr;34(4):353-7
pubmed: 404875
JPEN J Parenter Enteral Nutr. 2012 Mar;36(2):183-8
pubmed: 21825091
Biochim Biophys Acta. 2000 Sep 1;1523(1):128-34
pubmed: 11099867
J Diabetes Sci Technol. 2009 Jan;3(1):213-4
pubmed: 20046668
J Colloid Interface Sci. 2005 Jun 1;286(1):28-35
pubmed: 15848399
Can J Gastroenterol. 2010 Jul;24(7):453-7
pubmed: 20652162
Biochim Biophys Acta. 2005 Oct 10;1725(3):269-82
pubmed: 16165279
Anal Biochem. 1983 Nov;135(1):112-9
pubmed: 6670734
Middle East J Anaesthesiol. 2004 Jun;17(5):975-81
pubmed: 15449754
Diabetes Ther. 2018 Jun;9(3):1359-1367
pubmed: 29725969
Endocr Pract. 2018 Oct 2;24(10):900-906
pubmed: 30035626
JPEN J Parenter Enteral Nutr. 2013 Nov;37(6):755-62
pubmed: 23770842
Peptides. 1996;17(8):1323-30
pubmed: 8971927
JPEN J Parenter Enteral Nutr. 2018 Jul;42(5):907-912
pubmed: 30001464
Clin Chim Acta. 1982 Aug 4;123(1-2):193-8
pubmed: 6288288
Acta Biomater. 2013 Feb;9(2):5070-9
pubmed: 23022543
J Chromatogr Sci. 2012 Aug;50(7):586-90
pubmed: 22525877
Diabetes. 1976 Jan;25(1):72-4
pubmed: 1245268
JPEN J Parenter Enteral Nutr. 1990 May-Jun;14(3):262-4
pubmed: 2112639
Acta Pharm Nord. 1992;4(4):209-22
pubmed: 1294186
Nutr Clin Pract. 2019 Oct;34(5):775-782
pubmed: 30693980
Diabetes Technol Ther. 2012 Oct;14(10):912-6
pubmed: 22746979
J Chromatogr B Biomed Sci Appl. 2000 Nov 10;749(1):25-34
pubmed: 11129075
Biochem Biophys Res Commun. 1975 Jan 6;62(1):31-41
pubmed: 163080

Auteurs

Heloise Henry (H)

ULR7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University of Lille, F-59000 Lille, France.
Institut de Pharmacie, CHU Lille, F-59000 Lille, France.

Damien Lannoy (D)

ULR7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University of Lille, F-59000 Lille, France.
Institut de Pharmacie, CHU Lille, F-59000 Lille, France.

Patrice Maboudou (P)

Service de Biochimie Automatisée Protéines, CHU Lille, F-59000 Lille, France.

David Seguy (D)

Service Endocrinologie Diabétologie Maladies Métaboliques et Nutrition, CHU Lille, F-59000 Lille, France.
U1286-Infinite-Institute for Translational Research in Inflammation, University of Lille, F-59000 Lille, France.
Inserm, U1286, F-59000 Lille, France.

Thierry Dine (T)

ULR7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University of Lille, F-59000 Lille, France.

Pascal Pigny (P)

Laboratoire de Biochimie & Hormonologie, Centre de Biologie Pathologie, CHU Lille, F-59000 Lille, France.

Pascal Odou (P)

ULR7365-GRITA-Groupe de Recherche sur les Formes Injectables et les Technologies Associées, University of Lille, F-59000 Lille, France.
Institut de Pharmacie, CHU Lille, F-59000 Lille, France.

Classifications MeSH